94-19688. National Bioethics Advisory Commission Proposed Charter  

  • [Federal Register Volume 59, Number 155 (Friday, August 12, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-19688]
    
    
    [[Page Unknown]]
    
    [Federal Register: August 12, 1994]
    
    
    =======================================================================
    -----------------------------------------------------------------------
    
    OFFICE OF SCIENCE AND TECHNOLOGY
    
     
    
    National Bioethics Advisory Commission Proposed Charter
    
    AGENCY: Office of Science and Technology Policy (OSTP).
    
    ACTION: Request for Comments.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This notice describes a proposal to establish a National 
    Bioethics Advisory Commission within the Executive Branch. The 
    Commission would be charged to consider issues of bioethics arising 
    from research on human biology and behavior, and the applications of 
    that research.
    
    DATES: Comments must be received on or before October 11, 1994.
    
    ADDRESSES: Submit written comments by mail to: Bioethics Docket, Office 
    of Science and Technology Policy, Room 436, OEOB, Washington, D.C. 
    20500, or by FAX to: 202-456-6027.
    
    FOR FURTHER INFORMATION CONTACT:
    By mail: Rachel E. Levinson, Assistant Director for Life Sciences, 
    Office of Science and Technology Policy, Room 436, OEOB, Washington, 
    D.C. 20500. Office telephone number: 202-456-6137.
    
    SUPPLEMENTARY INFORMATION: OSTP proposes that a standing advisory body 
    be established within the Executive Branch to consider issues of 
    bioethics arising from research on human biology and behavior, and the 
    applications of that research. This action would fulfill a need 
    recognized by all branches of the Federal government. For example, a 
    report by the House of Representatives Committee on Government 
    Operations recommended establishment of an advisory committee to 
    examine the ethical, legal and social implications of the Human Genome 
    Project. The proposed advisory body would expand the work of the 
    National Commission for the Protection of Human Subjects of Biomedical 
    and Behavioral Research; the Department of Health, Education and 
    Welfare's Ethics Advisory Board; and the President's Commission for the 
    Study of Ethics Problems in Medicine and Biomedical and Behavioral 
    Research.
        OSTP seeks comments on a draft charter for a proposed National 
    Bioethics Advisory Commission (NBAC). The NBAC would report to the 
    President's National Science and Technology Council (NSTC). This 
    arrangement will facilitate access to the deliberations and 
    recommendations of the NBAC for the Executive Branch agencies most 
    heavily invested in biological and behavioral research.
        The Commission would be asked to identify and develop broad 
    overarching principles to govern the ethical conduct of biological and 
    behavioral research, and the applications of that research. The 
    proposed NBAC would not have responsibility for the review and approval 
    of individual projects.
        The draft charter seeks to strike a balance between defining the 
    NBAC's agenda so as to fulfill governmental needs, and allowing the 
    Commission sufficient flexibility to advise the government on issues 
    this group of experts and stakeholders believe should be addressed.
        The charter specifies two prospective areas of inquiry, issues in 
    the management and use of genetic information and protection of the 
    rights and welfare of research subjects. Discrete issues that full 
    under these two broad topics include: issues of genetic privacy, 
    screening for genetic disorders, intellectual property rights, access 
    to research data or materials developed with public funding, current 
    views on informed consent, adequacy and implementation of Federal human 
    subject research guidelines, and the concept of ``minimal risk.''
        In addition, several other potential issues for consideration by 
    the Commission have been raised in discussions to date including: 
    adequacy and implementation of Federal human subject research 
    guidelines, recommendations on requirements to maintain research data, 
    and the ethical aspects of access to costly health care technology. The 
    question is, how best might the scope of the Commission's charge be 
    defined so as to meet public needs for deliberation of pressing issues 
    in bioethics, without being so broad as to limit its effectiveness? An 
    alternative option for addressing the last issue, for example, might be 
    referral to a body more directly involved with decisions related to the 
    provisions of health care and relevant cost/benefit analysis.
        The Commission would be established in accordance with the Federal 
    Advisory Committee Act (FACA). As such, its meetings would be open tot 
    he public and announced in advance to facilitate public participation. 
    In addition, reports produced by the NBAC would be made available to 
    public either in toto, or in summary. The purpose of these efforts 
    would be to involve the public in the deliberations of the NBAC to the 
    greatest extent possible.
        As a FACA committee, the NBAC will be required to have a balanced 
    membership. Naturally, selection of Commission members is going to be a 
    delicate process that should take into account the social and cultural 
    mores of the times in order to establish a body that is sensitive to 
    the potential impacts of its deliberations and recommendations. The 
    draft charter proposes that members be appointed by the President. 
    Suggestions for potential members or membership posts are sought 
    through this Notice.
    
    Draft Charter
    
    Proposed National Bioethics Advisory Commission
    
    Purpose
    
        The National Bioethics Advisory Commission will provide advice and 
    make recommendations to the National Science and Technology Council, 
    other appropriate entities and the public, on bioethical issues arising 
    from research on human biology and behavior, and the applications of 
    that research.
    
    Authority
    
        42 U.S.C. 6617(a)(2). This Commission is governed by the provisions 
    of the Federal Advisory Committee Act (FACA), Public Law 92-463, as 
    amended (5 U.S.C. Appendix 2), which sets forth standards for the 
    formation of advisory committees, and implementing regulations (41 CFR 
    101-6.10).
    
    Functions
    
        The National Bioethics Advisory Commission shall advise, consult 
    with, and make recommendations to the National Science and Technology 
    Council and other appropriate entities, and also make their advice and 
    recommendations available to the public. The Commission's purview 
    includes the appropriateness of departmental, agency, or other 
    governmental programs, policies, assignments, missions, guidelines, and 
    regulations as they relate to bioethical issues arising from research 
    on human biology and behavior, and applications of that research. The 
    Commission shall identify broad, overarching principles to govern the 
    ethical conduct of research, citing individual projects only as 
    illustrations for such principles. The Commission shall not be 
    responsible for the review and approval of individual projects.
        As a first priority, the Commission will direct its attention to 
    consideration of:
    
    A. Issues in the management and use of genetic information; and
    B. Protection of the rights and welfare of research subjects.
    
        In receiving and responding to requests for advice and 
    recommendations from the National Science and Technology Council, the 
    Commission shall consider four criteria in establishing priority for 
    its activities:
    
    A. The public health or public policy urgency of the bioethical issue.
    B. The relation of the bioethical issue to the goals for Federal 
    investment in science and technology.
    C. The absence of another body able to fruitfully deliberate on the 
    bioethical issue.
    D. The extent of interest in the issue across the government. (The 
    Commission ordinarily will not deliberate on a bioethical issue of 
    interest to just one department or agency.)
    
        The Commission also shall have the authority to identify bioethical 
    issues, on its own behalf, for deliberation. The Commission will accept 
    suggestions of issues for consideration from Federal agencies, Congress 
    and the public. The Commission's decision to deliberate on a specific 
    topic shall be made in consultation with the National Science and 
    Technology Council. In all such instances, the four stated criteria for 
    establishing priority shall pertain.
    
    Structure
    
        The National Bioethics Advisory Commission shall consist of not 
    more than 15 members, including the Chairperson. Appointments shall be 
    made by the President, who shall select from knowledgeable non-
    Government experts and community representatives with special 
    qualifications and competence to deal effectively with bioethical 
    issues of concern to the participating departments and agencies. At 
    least one member shall be selected from each of the following 
    categories of primary expertise: (i) bioethics/theology; (ii) social/
    behavioral science; (iii) law; (iv) medicine/allied health professions; 
    and (v) biological research. At least three members shall be selected 
    from the general public, bringing to the Commission expertise other 
    than that listed. The membership shall be approximately evenly balanced 
    between scientists and non-scientists.
        Members shall be appointed for overlapping four-year terms. 
    Initially, members will be appointed for two-, three- or four-year 
    terms. Terms of more than two years are contingent upon renewal of the 
    National Bioethics Advisory Commission by appropriate action prior to 
    its termination. The Chairperson shall be appointed by the President. 
    The term of office for the Chairperson shall be two years, renewable by 
    appropriate action of the President.
        If a vacancy occurs on the Commission, the President shall make an 
    appointment to fulfill the term. Any member appointed to fill a vacancy 
    occurring prior to expiration of the term for which his or her 
    predecessor was appointed shall serve for the remainder of such term. 
    Members may serve after the expiration of their terms until their 
    successors have taken office.
        The Commission may conduct inquiries, hold hearings and establish 
    subcommittees, as necessary.
        The Commission is authorized to conduct analyses and develop 
    reports or other materials. In order to augment the expertise present 
    on the Commission, the Commission is also authorized to contract for 
    the services of non-governmental consultants who may conduct analyses, 
    prepare reports and background papers or prepare other materials for 
    consideration by the Commission, as appropriate.
        In order to avoid duplication of effort, the Commission may, in 
    lieu of, or as part of any of its authorized activities, incorporate 
    the results of the deliberations of another entity as long as the 
    Commission sets forth its reasons for doing so.
        The Assistant to the President for Science and Technology shall be 
    notified upon establishment of each subcommittee, and shall be provided 
    information on the name, membership (including chair), function, 
    estimated duration of the subcommittee, and estimated frequency of 
    meetings.
        Management and support services shall be provided by the Office for 
    Protection from Research Risks, Department of Health and Human 
    Services. Additional resources including, but not limited to personnel, 
    office support and printing will be provided by other NSTC member 
    agencies.
    
    Meetings
    
        Meetings of the Commission shall be held up to 10 times a year at 
    the call of the Chairperson with the advance approval of a Federal 
    Government official who shall also approve the agenda. Meetings of the 
    subcommittee(s) shall be convened as necessary. A Federal Government 
    official shall be present at all meetings.
        Meetings shall be open to the public except as determined otherwise 
    by the Assistant to the President for Science and Technology. Advance 
    notice of all meetings shall be given to the public.
        Meetings shall be conducted, and records of proceedings kept, as 
    required by applicable laws and Federal regulations.
    
    Compensation
    
        Members may be compensated at a rate not to exceed the maximum pay 
    authorized by 5 U.S.C. 3109, plus per diem and travel expenses as in 
    accordance with standard government travel regulations.
    
    Annual Cost Estimate
    
        The estimated annual cost for operating the National Bioethics 
    Advisory Commission, including compensation and travel expenses for 
    members and contracting and publication services costs, but excluding 
    that for staff support, $1,500,000. The estimated annual person years 
    of staff support is six, at an estimated annual cost of $500,000.
    
    Reports
    
        Reports by the National Bioethics Advisory Commission on specific 
    issues shall be submitted to the National Science and Technology 
    Council, the appropriate committees of Congress, and other appropriate 
    entities. The Commission may specifically identify the Federal 
    department, agency or other entity to which particular recommendations 
    are directed and request a response from the Federal department, agency 
    or other entity within 180 days of publication of such recommendations.
        Executive summaries of each report of the Commission shall be 
    promulgated in the Federal Register. Such summaries shall specifically 
    list the department, agency, or other entity to which any 
    recommendations are directed and the date by which such responses are 
    expected.
        An annual report shall be submitted to the National Science and 
    Technology Council and the appropriate committees of Congress. It shall 
    contain, at a minimum, (i) the Commission's function; (ii) a list of 
    members and their business addresses; (iii) the dates and places of 
    meetings; (iv) a summary of the Commission's activities during the 
    year; (v) a summary of the Commission's recommendations made during the 
    year; and (vi) a summary of responses made by departments, agencies, or 
    other entities to the Commission's recommendations during the year.
    
    Termination Date
    
        Unless renewed by appropriate action prior to its expiration, this 
    National Bioethics Advisory Commission will terminate two years from 
    the date this charter is approved.
    Barbara Ann Ferguson,
    Administrative Officer, Office of Science and Technology Policy.
    [FR Doc. 94-19688 Filed 8-11-94]
    BILLING CODE 3170-01 OSTP-M
    
    
    

Document Information

Published:
08/12/1994
Department:
Science and Technology Policy Office
Entry Type:
Uncategorized Document
Action:
Request for Comments.
Document Number:
94-19688
Dates:
Comments must be received on or before October 11, 1994.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: August 12, 1994